Brief: Oryzon Decides To Increase Amount Of Capital Increase To 30 Mln Euros

ORYZON Genomics SA

24/04/2025 07:18

April 24 (Reuters) - Oryzon Genomics SA ORY.MC:

DECIDED TO INCREASE AMOUNT OF CAPITAL INCREASE TO 30 MILLION EUROS, WITH THIS CAPITAL INCREASE BEING SIGNIFICANTLY OVERSUBSCRIBED

NUMBER OF NEW SHARES TO BE ISSUED: 12.8 MILLION

ISSUE PRICE: 2.35 EUROS PER SHARE, OF WHICH 0.05 EUROS CORRESPOND TO NOMINAL VALUE AND 2.30 EUROS TO SHARE PREMIUM

ISSUE PRICE REPRESENTS DISCOUNT OF 15.44% ON FIVE-DAY VOLUME WEIGHTED AVERAGE PRICE OF CO'S SHARES PRIOR TO APRIL 22

CAPITAL INCREASE REPRESENTS 19.41% CO'S SHARE CAPITAL BEFORE CAPITAL INCREASE AND 16.25% AFTER CAPITAL INCREASE

Source text: ID:nCNM4RDhd6 nFWN3R11AB

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))